OptiScan BioMedical

OptiScan Biomedical has developed an automated bedside blood monitoring platform for use in the surgical intensive care setting.  The OptiScanner® 5000 automatically monitors and trends glucose, prominently displaying trend data updated every 15 minutes, to help manage the patient’s glucose levels within an optimum, user-defined, glucose range.  The OptiScanner platform is being expanded to detect additional metabolic and hemodynamic analytes using the same micro-sample of blood.